TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal April 25, 2003
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992